衰弱与医疗急救团队审查后收入ICU患者的一年生存率:一项基于登记系统的回顾性研究
该回顾性登记队列研究纳入2018年1月1日至2022年6月30日期间184个ICU收治的48,425例有临床衰弱量表(CFS)评分的成人患者(≥16岁),评估医疗急救团队审查后收入ICU时衰弱与一年死亡率的关系。衰弱采用CFS 1-8分类评估,主要终点为通过国家死亡登记系统确认的一年死亡率。调整后一年死亡概率从CFS-1的12.3%逐步升至CFS-8的60.8%,与CFS-1相比,CFS-3以上风险增加。作者认为应将衰弱评估纳入医疗急救团队和ICU决策,以指导个体化、符合患者目标的照护。
要点
- 在48,425例医疗急救团队审查后收入ICU的成人患者中,调整后一年死亡概率从CFS-1的12.3%逐步升高至CFS-8的60.8%。
- 与CFS-1相比,CFS-3以上患者一年死亡风险增加,调整后归因死亡风险从CFS-2的+5.6%(95%CI: 2.8-8.4%)到CFS-8的+48.5%(95%CI: 43.6-53.4%)。
- 衰弱评分较高的患者年龄更大、更常存在治疗限制和更重的慢性病负担。
- 作者认为应将衰弱评估纳入医疗急救团队和ICU决策,以指导个体化、符合患者目标的照护。
适用人群与场景
- 成人患者(≥16岁),于2018年1月1日至2022年6月30日期间收入184个ICU,且有记录的临床衰弱量表(CFS)评分。
- 患者均在此前接受过病房医疗急救团队(MET)审查。
诊断标准与关键阈值
- 衰弱采用临床衰弱量表(CFS)1-8分类评估。
研究设计与关键结果
- 研究类型:基于澳大利亚和新西兰重症监护学会成人患者数据库的回顾性登记队列研究。
- 样本量:48,425例成人患者,来自184个ICU。
- 干预:无。
- 主要终点:一年死亡率,通过链接相应国家死亡登记系统确认。
- 调整后一年死亡概率从CFS-1的12.3%逐步升高至CFS-8的60.8%。
- 与CFS-1相比,CFS-3以上风险增加;调整后归因死亡风险从CFS-2的+5.6%(95%CI: 2.8-8.4%)到CFS-8的+48.5%(95%CI: 43.6-53.4%)。
- 衰弱评分较高的患者年龄更大、更常存在治疗限制和更重的慢性病负担。
证据类型、等级与局限
- 证据类型:回顾性登记队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为应将衰弱评估纳入医疗急救团队和ICU决策,以指导个体化、符合患者目标的照护。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The association between frailty and long-term outcomes following intensive care unit (ICU) admission after a medical emergency team (MET) review is poorly understood.
OBJECTIVE: To evaluate whether frailty was associated with increased one-year mortality among ICU patients admitted after a ward MET review.
DESIGN: Retrospective registry-based cohort study using the Australian and New Zealand Intensive Care Society Adult Patient Database.
SETTING AND PARTICIPANTS: Adult patients (≥16 years) admitted to 184 ICUs between 1 January 2018 and 30 June 2022 with a documented Clinical Frailty Scale (CFS) score were included.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Frailty was assessed categorically using the CFS 1-8. The primary outcome was one-year mortality, ascertained via linkage with respective national death registries. Associations between frailty and one-year mortality were evaluated using multivariable hierarchical logistic regression. A total of 48,425 patients were included. Patients with higher frailty scores were older, more likely to have treatment limitations and a greater chronic disease burden. The adjusted probability of one-year mortality increased progressively from 12.3% for CFS-1 to 60.8% for CFS-8. Compared with CFS-1, increased risk was observed beyond CFS-3, with the adjusted attributable mortality risk ranging from +5.6% (95%CI: 2.8-8.4%) for CFS-2 to +48.5% (95%CI: 43.6-53.4%) for CFS-8.
CONCLUSIONS: In this large cohort of ICU patients admitted after a MET review, frailty was independently associated with higher one-year mortality, with outcomes worsening progressively with incrementing CFS. Our findings highlight the importance of incorporating frailty assessment into MET and ICU decision-making to guide individualised, goal-concordant care.
参考来源
- White A, Ling RR, Orosz J, et al. Frailty and one year survival in patients admitted to the intensive care unit following a medical emergency team review: a retrospective registry-based study. Resuscitation. 2026. PMID: 41651187. doi:10.1016/j.resuscitation.2026.110995
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。